VALBIOTIS at the International BIO Convention in San Diego from June 19 to 22, 2017.
77th scientific sessions of American Diabetes AssociationJune 12th 2017
VALBIOTIS presents the results of its phase I/II clinical trial to evaluate TOTUM-63 (active ingredient of Valedia®) for managing prediabetes at the 77th scientific sessions of American Diabetes Association – San Diego Convention Center, San Diego, June 9 to 13, 2017.View press release
Francophone Diabetes Society Congress 2017March 27th 2017
VALBIOTIS at Francophone Diabetes Society Congress in Lille, from March 28 to 31, 2017. The VALBIOTIS team presents its results: "CA-001 - TOTUM-63 (active ingredient of Valedia®) improves insulin sensitivity and limits fat intake in mice fed a high-fat diet." View poster
Bio Spring BarcelonaFebruary 21st 2017
VALBIOTIS at the BIO SPRING in Barcelona, from March 20 to 22, 2017.